PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial-Reference-Cited by-同舟云学术

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial

Published:2023-10 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Ost Piet^ORCID,Siva Shankar,Brabrand Sigmund,Dirix Piet,Liefhooghe Nick,Otte François-Xavier,Gomez-Iturriaga Alfonso,Everaerts Wouter,Shelan Mohamed,Conde-Moreno Antonio,López Campos Fernando,Papachristofilou Alexandros,Guckenberger Matthias,Scorsetti Marta,Zapatero Almudena,Villafranca Iturre Ana-Elena,Eito Clara,Couñago Felipe,Muto Paolo,Van De Voorde Lien,Mach Nicolas,Bultijnck Renée,Fonteyne Valérie,Moon Daniel,Thon Kristian,Mercier Carole,Achard Vérane,Stellamans Karin,Goetghebeur Els,Reynders Dries,Zilli Thomas

Funder

Movember Foundation

Kom op tegen Kanker

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference18 articles.

1. Prevalence and prognosis of low-volume, oligorecurrent, hormone-sensitive prostate cancer amenable to lesion ablative therapy;De Bruycker;BJU Int,2017

2. Incorporating prostate-specific membrane antigen positron emission tomography in management decisions for men with newly diagnosed or biochemically recurrent prostate cancer;Bukavina;Eur Urol,2023

3. Salvage lymph node dissection for nodal recurrent prostate cancer: a systematic review;Ploussard;Eur Urol,2019

4. Recommendations for radiation therapy in oligometastatic prostate cancer: an ESTRO-ACROP Delphi consensus;Zilli;Radiother Oncol,2022

5. Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review;Achard;Acta Oncol,2020

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refining salvage radiotherapy strategies for pelvic node recurrence in prostate cancer: insights from salvage lymph node dissection;European Journal of Nuclear Medicine and Molecular Imaging;2024-09-05

2. Coverage with evidence development program on stereotactic body radiotherapy in Belgium (2013–2019): a nationwide registry-based prospective study;The Lancet Regional Health - Europe;2024-09

3. Organ-confined pT2 ISUP4/5 vs. nonorgan confined pT3/4 ISUP2 vs. ISUP3 prostate cancer: Differences in biochemical recurrence-free survival after radical prostatectomy;Urologic Oncology: Seminars and Original Investigations;2024-07

4. Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-28

5. OLIGOPELVIS and the “All You Can Eat” Strategy for Oligorecurrent Nodal Prostate Cancer: Are We Already Full?;European Urology;2024-04